Condition
Stage IVC Nasopharyngeal Carcinoma
Total Trials
2
Recruiting
0
Active
0
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 80/100
Termination Rate
50.0%
1 terminated out of 2 trials
Success Rate
0.0%
-86.5% vs benchmark
Late-Stage Pipeline
50%
1 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
0
Data Visualizations
Phase Distribution
2Total
Not Applicable (1)
P 3 (1)
Trial Status
Unknown1
Terminated1
Clinical Trials (2)
Showing 2 of 2 trials
NCT03049358Not ApplicableTerminated
Olfactory Training in Improving Sense of Smell After Radiation Therapy in Patients With Paranasal Sinus or Nasopharyngeal Cancer
NCT01915134Phase 3Unknown
Endostatin in Combination With Chemotherapy for Metastatic Nasopharyngeal Carcinoma
Showing all 2 trials